Can Prednisone Raise A1C Levels?

Prednisone can raise A1C levels, and the effect scales with dose. Research on patients treated for giant cell arteritis found that each additional milligram of daily prednisone was associated with a measurable bump in A1C, with the increase roughly three to four times larger in people who already had diabetes compared to those who did not.¹ The connection is not subtle or speculative. Glucocorticoids are one of the most well-recognized drug classes for disrupting blood sugar control, and A1C, which reflects average blood sugar over two to three months, captures that disruption over time.

How Prednisone Disrupts Blood Sugar

Prednisone belongs to a class of drugs called glucocorticoids, and the “gluco” in the name is a hint. These drugs interfere with glucose handling in multiple ways at once. They make your liver pump out more glucose, reduce the ability of muscle and fat tissue to absorb that glucose, and impair the effectiveness of insulin your pancreas produces. The net result is higher blood sugar, particularly after meals and through the afternoon and evening hours.²

This is not an occasional side effect that happens to a few unlucky people. Hyperglycemia is one of the most common consequences of glucocorticoid therapy, occurring in people both with and without a prior diabetes diagnosis.³ A study using continuous glucose monitors on patients receiving steroids for skin conditions found that steroid-induced hyperglycemia showed up in about half of all treated patients. Even among those who had perfectly normal blood sugar before starting treatment, two out of ten developed hyperglycemia.⁴

The timing of blood sugar spikes on prednisone is distinctive. Because most people take their dose in the morning, blood sugar tends to rise through the afternoon and stay elevated into the evening. Fasting morning readings may look deceptively normal, which is one reason steroid-induced hyperglycemia can go unnoticed with standard lab work that only checks fasting glucose.

Higher Doses Mean Higher A1C

The relationship between prednisone dose and A1C is not all-or-nothing. It follows a dose-response pattern, meaning more prednisone leads to more A1C elevation. In a study of patients being treated for giant cell arteritis, researchers found that for every additional milligram of daily prednisone, A1C increased by about 0.005 percent in people without diabetes and by about 0.018 percent in those with existing diabetes.¹ That may sound tiny per milligram, but prednisone is often prescribed at 20, 40, or 60 milligrams a day. At those doses, the numbers add up quickly.

Separately, in patients with type 2 diabetes who were treated with corticosteroids for a flare of chronic obstructive pulmonary disease, the total steroid dose predicted how much A1C climbed.⁵ In practical terms, this means a short five-day burst of high-dose prednisone and a months-long taper both push A1C upward, but the longer and higher the exposure, the more pronounced the effect. Your doctor’s goal of tapering you off as quickly as your condition allows is partly about protecting your metabolic health.

Even Low Doses Are Not Innocent

One common misconception is that only high doses of prednisone affect blood sugar. Low-dose steroid regimens, such as those used long-term in transplant recipients, also leave a footprint on A1C. A study following kidney transplant patients on chronic low-dose steroids found a small but statistically real difference in A1C between those on steroids and those who were not, and the steroid group had roughly 1.8 times the risk of progressing to pre-diabetes.⁶ The absolute difference in A1C was modest, on the order of a tenth of a percentage point, but when someone is hovering near the boundary between normal glucose tolerance and pre-diabetes, even a small push matters.

This is worth knowing if you are on a long-term maintenance dose of prednisone for a condition like lupus, rheumatoid arthritis, or an organ transplant. Even at 5 or 7.5 milligrams a day, the drug is nudging your blood sugar higher than it would otherwise be. Over months and years, that nudge can translate to a meaningful change in A1C and a higher chance of crossing into pre-diabetic or diabetic territory.

Who Faces the Biggest Risk

Some people are far more vulnerable to prednisone’s blood sugar effects than others. The single biggest risk factor is already having diabetes or pre-diabetes. As the giant cell arteritis study showed, the per-milligram effect on A1C was about three and a half times greater in patients with existing diabetes compared to those without it.¹ If your blood sugar regulation is already strained, prednisone overwhelms whatever compensatory capacity your body has left.

Age is another independent risk factor. In the kidney transplant study, advancing age predicted progression to both pre-diabetes and new-onset diabetes after transplantation, separate from the steroid effect.⁶ Higher body mass index was also linked to a greater risk of developing full-blown new-onset diabetes, which makes sense: carrying extra weight already increases insulin resistance, and prednisone piles on additional resistance.

The continuous glucose monitoring study found that the severity of blood sugar disruption roughly doubled with each step up in pre-existing glucose impairment. Among those who already had pre-diabetes before starting steroids, four out of ten developed steroid-induced hyperglycemia. Among those who already had diabetes, nine out of ten did.⁴ Those with steroid-induced hyperglycemia spent nearly six hours per day above their target glucose range, with about an hour and a quarter per day in severely high territory. That kind of daily glucose exposure, sustained over weeks, is exactly what drives A1C upward.

How Prednisone Compares to Other Steroids

Not all corticosteroids hit blood sugar equally hard. A hospital study comparing different oral and intravenous steroids found that dexamethasone and methylprednisolone raised blood glucose more than prednisone (or its closely related form, prednisolone) and hydrocortisone. Dexamethasone produced mean blood glucose readings about 20 mg/dL higher than prednisolone, and methylprednisolone ran roughly 27 mg/dL higher than prednisolone over a seven-day period.⁷

Why the difference? It partly comes down to potency and duration of action. Dexamethasone is a much more potent glucocorticoid milligram-for-milligram and has a longer half-life, meaning it suppresses insulin sensitivity for a greater portion of the day. Methylprednisolone, often given intravenously in hospital settings, also tends to produce higher blood glucose readings than oral prednisone. So if you have been switched from prednisone to dexamethasone or methylprednisolone, the blood sugar impact may be noticeably worse even if the dose seems equivalent on paper. Conversely, hydrocortisone, which is weaker and shorter-acting, tends to produce less hyperglycemia.

This is clinically relevant because doctors sometimes have a choice of which steroid to prescribe. When blood sugar control is a concern, the choice of agent, not just the dose, can make a meaningful difference.

Why Standard Blood Tests Can Miss the Problem

One frustrating wrinkle is that prednisone’s effect on blood sugar often hides from routine lab work. If your doctor checks a fasting glucose in the morning, you may get a reassuringly normal result because prednisone’s glucose-raising effect peaks in the afternoon and evening, not first thing in the morning. A1C is better at catching this pattern because it reflects average glucose over months rather than a single snapshot, but even A1C has a lag. A short course of prednisone lasting a week or two may spike your daily blood sugars dramatically without budging your A1C much, because A1C is weighted toward longer-term averages.

Continuous glucose monitors offer the most revealing picture. The dermatology study that placed monitors on patients starting steroids caught hyperglycemia in nearly half of treated patients, including some who would have looked perfectly normal on standard lab draws.⁴ For people on longer courses of prednisone, asking your doctor about more frequent glucose checks, afternoon or post-meal readings rather than fasting-only labs, or even a short trial with a continuous glucose monitor can give you a much clearer picture of what is actually happening.

Managing Blood Sugar While on Prednisone

If you need prednisone and cannot simply stop taking it, there are strategies to limit the damage to your blood sugar. Diet and physical activity are the starting point for everyone on glucocorticoid therapy.⁸ Reducing refined carbohydrates and timing meals to avoid large glucose loads in the afternoon, when prednisone’s effect is strongest, can help blunt the spikes.

When lifestyle changes are not enough, medication options include metformin, a class of drugs called DPP-4 inhibitors, and intermediate-acting insulin (often called NPH insulin), which can be timed to match prednisone’s glucose-raising peak.⁹ NPH insulin is particularly well suited because its duration of action lines up nicely with prednisone’s glucose-elevating window. If you take prednisone in the morning, a dose of NPH given around the same time will be working hardest through the afternoon, right when you need it most.

For people who already have diabetes and are managing it with insulin, starting prednisone almost always means adjusting your insulin regimen. The adjustment is often substantial. This is a conversation to have with your doctor proactively, ideally before you start the steroid, not after your blood sugars have been running high for a week. A practical guide on managing steroid-induced hyperglycemia in hospital settings emphasized that the problem frequently causes or worsens blood sugar control in patients with known diabetes and can trigger new hyperglycemia in those without a diabetes history.¹⁰

Does A1C Come Back Down After Stopping Prednisone

For many people, the answer is yes, but the timeline depends on how long you were on the drug and what your baseline glucose metabolism looked like before you started. A1C reflects average glucose over roughly two to three months, so even after you stop prednisone, it takes that long for the number to fully reflect your new, steroid-free reality. If you were on a short course, you may not see much A1C change at all because the window of high blood sugar was too brief to significantly shift a three-month average.

The dose-response relationship works in reverse during a taper. As your daily dose drops, the per-milligram contribution to A1C diminishes proportionally.¹ So if you are tapering from 40 mg down to 5 mg over several months, your blood sugar should improve gradually along the way, not all at once when you reach zero.

The situation is less predictable for people who were on high-dose or prolonged steroid therapy and developed new-onset diabetes during treatment. Some of them return to normal glucose tolerance after stopping. Others, particularly those with pre-existing risk factors like obesity, older age, or a family history of diabetes, find that prednisone essentially unmasked a diabetic tendency that was already developing and does not fully reverse. If you developed diabetes while on steroids and your A1C does not normalize within a few months of stopping, it is worth following up rather than assuming things will eventually sort themselves out.

Steroid Effects on Blood Sugar in Children

Prednisone’s glucose effects are not limited to adults. Children treated with steroids for conditions like nephrotic syndrome also show elevated blood sugar and A1C. A study of children with nephrotic syndrome found that those treated with steroids had a mean A1C of 5.0 percent compared to 4.4 percent in untreated controls, along with meaningfully higher blood glucose levels.¹¹ While these values are still within what most labs would call a normal range, the gap between treated and untreated children was consistent and statistically clear.

This matters because pediatric steroid courses for conditions like nephrotic syndrome, asthma, or inflammatory bowel disease can be long and repeated. Parents often worry about growth suppression and bone health on steroids but may not think about glucose effects. Pediatricians generally do not screen children’s A1C during steroid courses the way internists might for adults, partly because steroid-induced diabetes in children is rarer. Still, if your child is on frequent or prolonged steroid courses, it is reasonable to ask their doctor whether periodic glucose monitoring makes sense.

When A1C Might Not Tell the Whole Story

A1C is a useful marker, but it has limitations that become especially relevant during steroid therapy. Because it averages blood sugar over months, a short but intense spike in glucose from a brief prednisone course may barely register on A1C while still causing symptoms like excessive thirst, frequent urination, and fatigue. A person who takes a ten-day burst of prednisone at 40 mg per day and experiences blood sugars in the 200s or 300s every afternoon will likely feel terrible, but their A1C checked a month later might show only a modest bump.

Certain medical conditions can also make A1C less reliable regardless of steroids. Anything that changes how long red blood cells survive, such as anemia, recent blood transfusions, or kidney disease, can falsely raise or lower A1C. Since many people taking long-term prednisone also have chronic inflammatory or autoimmune conditions that can affect red blood cell turnover, this is not a purely theoretical concern. If your A1C does not match how you feel or what your home glucose readings show, alternative markers like fructosamine, which reflects average blood sugar over a shorter window of about two to three weeks, can fill the gap. Continuous glucose monitoring, as discussed above, is another option that bypasses the limitations of any single lab value.